Chemotherapy-free hematopoietic stem cell transplantation cures adult sickle cell disease patients.
No treatment-related mortality or graft-versus-host disease occurred after alemtuzumab/total body irradiation conditioning in sickle cell disease adults.
Health-related quality of life improves in adult sickle cell disease patients after chemotherapy-free hematopoietic stem cell transplantation.